PubMed Tkalcevic, V.I., Cuzic, S., Brajsa, K., Mildner, B., Bokulic, A., Situm, K., Perovic, D., Glojnaric, I., & Parnham, M.J
Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice
Also, any comparisons that cite only scientific evidence should also include a disclaimer that such references are for informational purposes only and do not imply FDA endorsement or evaluation
What the Published Data Shows The STEP trials, which established semaglutide's efficacy for weight management, studied the drug at 2.4 mg weekly
I encourage clinicians not to let this moment pass
Protein is not a trend - its infrastructure